does glp 1 lower your immune system GLP-1 and Gut Health: Addressing Metabolic Dysfunction for Physicians The conversation around GLP-1s is

The Congressional Budget Office (CBO) has stated, "The developing market for [anti-obesity medications] could significantly affect health care spending and the federal budget." They contend that passage of the Treat and Reduce Obesity Act would increase costs for anti-obesity medications (i.e., because more people would use them) but reduce federal costs for other related health issues

The enhancement of Nrf2 transcription with sulforaphane or melatonin could benefit patients with LONG COVID (Post-Acute Sequelae of SARS-CoV-2 or Post-COVID-Syndrome), a significant proportion (approximately 40%) of individuals with COVID-19 experiencing a variety of symptoms (loss of smell and/or taste, fatigue, cough, aching pain, brain fog, insomnia, shortness of breath, and tachycardia) after 12 weeks (Jarrott et al., 2022

First, retatrutide phase 3 data are currently available as topline company-reported results, and full peer-reviewed publication is needed

their heterogeneity is the formidable, unmet drug resistance challenge

Osteoarthritis Cartilage 33 , 518529 (2024)